Lipella Pharmaceuticals Inc. (LIPO): Total Liabilities
Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$754.4K
As of 2024-12-31
$862.2K
As of 2025-09-30
+8.6%
3-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $754.4K | +74.3% | 2025-03-28, Balance as of period end |
| 2023-12-31 | $432.7K | -66.0% | 2025-03-28, Balance as of period end |
| 2022-12-31 | $1.27M | +116.3% | 2024-02-27, Balance as of period end |
| 2021-12-31 | $589.3K | n/a | 2023-03-31, Balance as of period end |